Vanguard Group Inc Novo Cure LTD Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
277Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Black Rock Inc. New York, NY9.08MShares$156 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$152 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$57.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$40.8 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA2.31MShares$39.5 Million0.01% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.8B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...